Changes in bone structure and the muscle-bone unit in children with chronic kidney disease

Kidney International

Volumn 83, Issue 3, 2013, Pages 495-502

  Tsampalieros, Anne ^a,b   Kalkwarf, Heidi J ^c   Wetzsteon, Rachel J ^b   Shults, Justine ^b   Zemel, Babette S ^b   Foster, Bethany J ^d,e   Foerster, Debbie L ^b   Leonard, Mary B ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d MONTREAL CHILDREN S HOSPITAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CALCITRIOL; GLUCOCORTICOID; GROWTH HORMONE; PHOSPHATE BINDING AGENT; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE LENGTH; BONE STRUCTURE; CHILD; CHILD CARE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; ETHNICITY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MUSCULOSKELETAL FUNCTION; OUTCOME ASSESSMENT; PERIOSTEUM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; SCHOOL CHILD; SECONDARY HYPERPARATHYROIDISM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIBIA;

EID: 84874656322     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.347     Document Type: Article

References (57)

1. Foster BJ, Kalkwarf HJ, Shults J et al. Association of chronic kidney disease with muscle deficits in children. J Am Soc Nephrol 2011; 22: 377-386
2. Wetzsteon RJ, Kalkwarf HJ, Shults J et al. Volumetric bone mineral density and bone structure in childhood chronic kidney disease. J Bone Miner Res 2011; 26: 2235-2244
3. Pluskiewicz W, Adamczyk P, Drozdzowska B et al. Skeletal status in adolescents with end-stage renal failure: A longitudinal study. Osteoporos Int 2005; 16: 289-295
4. Swolin-Eide D, Magnusson P, Hansson S. Bone mass, biochemical markers and growth in children with chronic kidney disease: A 1-year prospective study. Acta Paediatr 2007; 96: 720-725
5. Johnson VL, Wang J, Kaskel FJ et al. Changes in body composition of children with chronic renal failure on growth hormone. Pediatr Nephrol 2000; 14: 695-700
6. Van Dyck M, Gyssels A, Proesmans W et al. Growth hormone treatment enhances bone mineralisation in children with chronic renal failure. Eur J Pediatr 2001; 160: 359-363
7. Parfitt AM. A structural approach to renal bone disease. J Bone Miner Res 1998; 13: 1213-1220
8. Zemel BS, Leonard MB, Kelly A et al. Height adjustment in assessing dual energy X-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 2010; 95: 1265-1273
9. Leonard MB, Elmi A, Mostoufi-Moab S et al. Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. J Clin Endocrinol Metab 2010; 95: 1681-1689
10. Terpstra AM, Kalkwarf HJ, Shults J et al. Bone density and cortical structure after pediatric renal transplantation. J Am Soc Nephrol 2012; 23: 715-726
11. K/DOQI Clinical. Practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 2005; 46(Suppl 1): 1-103
12. Klaus G, Watson A, Edefonti A et al. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 2006; 21: 151-159
13. Schoenau E, Neu CM, Beck B et al. Bone mineral content per muscle crosssectional area as an index of the functional muscle-bone unit. J Bone Miner Res 2002; 17: 1095-1101
14. Obatake N, Ishimura E, Tsuchida T et al. Annual change in bone mineral density in predialysis patients with chronic renal failure: Significance of a decrease in serum 1,25-dihydroxy-vitamin D. J Bone Miner Metab 2007; 25: 74-79
15. Fujimori A, Okada S, Sakai M et al. Relationship between biochemical markers and radial cortical bone changes in hemodialysis patients. Nephron Clin Pract 2011; 118: C375-c379
16. Behnke B, Altrogge H, Delling G et al. Bone mineral density in pediatric patients after renal transplantation. Clin Nephrol 1996; 46: 24-29
17. Behnke B, Kemper MJ, Kruse HP et al. Bone mineral density in children with primary hyperoxaluria type I. Nephrol Dial Transplant 2001; 16: 2236-2239
18. Lima EM, Goodman WG, Kuizon BD et al. Bone density measurements in pediatric patients with renal osteodystrophy. Pediatr Nephrol 2003; 18: 554-559
19. Tenbrock K, Kruppa S, Mokov E et al. Analysis of muscle strength and bone structure in children with renal disease. Pediatr Nephrol 2000; 14: 669-672
20. Mehls O, Ritz E, Krempien B et al. Roentgenological signs in the skeleton of uremic children. An analysis of the anatomical principles underlying the roentgenological changes. Pediatr Radiol 1973; 1: 183-190
21. Fox J, Miller MA, Newman MK et al. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys. Bone 2007; 41: 321-330
22. Ma YL, Marin F, Stepan J et al. Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis. Bone 2011; 48: 972-978
23. Schober HC, Han ZH, Foldes AJ et al. Mineralized bone loss at different sites in dialysis patients: Implications for prevention. J Am Soc Nephrol 1998; 9: 1225-1233
24. Martin KJ, Gonzalez EA. Parathyroid hormone assay: Problems and opportunities. Pediatr Nephrol 2007; 22: 1651-1654
25. Boot AM, Nauta J, de Jong MC et al. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment. Clin Endocrinol (Oxf) 1998; 49: 665-672
26. van der Sluis IM, Boot AM, Nauta J et al. Bone density and body composition in chronic renal failure: Effects of growth hormone treatment. Pediatr Nephrol 2000; 15: 221-228
27. Lanes R, Gunczler P, Orta N et al. Changes in bone mineral density, growth velocity and renal function of prepubertal uremic children during growth hormone treatment. Horm Res 1996; 46: 263-268
28. Schweizer R, Martin DD, Schwarze CP et al. Cortical bone density is normal in prepubertal children with growth hormone (GH) deficiency, but initially decreases during GH replacement due to early bone remodeling. J Clin Endocrinol Metab 2003; 88: 5266-5272
29. Ruth EM, Weber LT, Schoenau E et al. Analysis of the functional musclebone unit of the forearm in pediatric renal transplant recipients. Kidney Int 2004; 66: 1694-1706
30. Clapp EL, Bevington A, Smith AC. Exercise for children with chronic kidney disease and end-stage renal disease. Pediatr Nephrol 2012; 27: 165-172
31. Weaver DJ Jr, Kimball TR, Knilans T et al. Decreased maximal aerobic capacity in pediatric chronic kidney disease. J Am Soc Nephrol 2008; 19: 624-630
32. Alayli G, Ozkaya O, Bek K et al. Physical function, muscle strength and muscle mass in children on peritoneal dialysis. Pediatr Nephrol 2008; 23: 639-644
33. Jamal SA, Cheung AM, West SL et al. Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease. Osteoporos Int 2012; e-pub ahead of print
34. Jamal SA, Gilbert J, Gordon C et al. Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 2006; 21: 543-548
35. Cooper C, Dennison EM, Leufkens HG et al. Epidemiology of childhood fractures in Britain: A study using the general practice research database. J Bone Miner Res 2004; 19: 1976-1981
36. Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953
37. Wesseling-Perry K, Pereira RC, Tseng CH et al. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2012; 7: 146-152
38. Griffin LM, Kalkwarf HJ, Zemel BS et al. Assessment of dual-energy X-ray absorptiometry measures of bone health in pediatric chronic kidney disease. Pediatr Nephrol 27: 1139-1148 2012
39. Kalkwarf H, Denburg M, Strife C et al. Vitamin D status in children and adolescents with chronic kidney disease. Kidney Int 2012; 81: 690-697
40. Tuchman S, Thayu M, Shults J et al. Interpretation of biomarkers of bone metabolism in children: Impact of growth velocity and body size in healthy children and chronic disease. J Pediatr 2008; 153: 484-490
41. Thayu M, Denson LA, Shults J et al. Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease. Gastroenterology 2010; 139: 430-438
42. Tanner J, Whitehouse R, Marshall W et al. Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method). Academic Press: London, England, 1975
43. Morris N, Udry J. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc 1980; 9: 271-280
44. Aaron DJ, Kriska AM, Dearwater SR et al. Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescents. Am J Epidemiol 1995; 142: 191-201
45. Kemper HC, Bakker I, Twisk JW et al. Validation of a physical activity questionnaire to measure the effect of mechanical strain on bone mass. Bone 2002; 30: 799-804
46. Wetzsteon RJ, Zemel BS, Shults J et al. Mechanical loads and cortical bone geometry in healthy children and young adults. Bone 2011; 48: 1103-1108
47. Serum-Calcium. Lancet 1979; 1: 858-859
48. Gao P, Scheibel S, D'Amour P et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 2001; 16: 605-614
49. Schwartz GJ, Munoz A, Schneider MF et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629-637
50. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266
51. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998; 316: 1236-1238
52. Ogden CL, Kuczmarski RJ, Flegal KM et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109: 45-60
53. Dubner SE, Shults J, Baldassano RN et al. Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology 2009; 136: 123-130
54. Wetzsteon RJ, Shults J, Zemel BS et al. Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res 2009; 24: 503-513
55. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44: 45-60
56. Cole T, Green P. LMS Chartmaker Pro 2006
57. Wetzsteon R, Zemel B, Shults J et al. Mechanical loads and cortical bone geometry in healthy children and young adults. Bone 2011; 48: 1103